China Dasheng Biotechnology Company (CDBT) Stock

About China Dasheng Biotechnology Company

China Dasheng Biotechnology Company, alongside its various divisions, is dedicated to the creation, promotion, and distribution of microbial products within the People's Republic of China. These specialized solutions primarily function as beneficial additives for both livestock feed and agricultural cultivation. The company's product line features proprietary blends of Artificial Microorganisms (AM) and High-efficiency Microorganisms (HM), in addition to biological preservatives. Its AM/HM bacteria-based additives for crops, including specific strains like Bulgaria lactobacillus, beer microzyme, and dark red spirilla, are formulated to significantly boost beneficial microbial populations in soil. They also work to counteract the proliferation of harmful fungi and putrefactive bacteria, thereby optimizing nutrient absorption and helping to reduce the incidence of diseases in both plants and animals. For animal nutrition, the AM/HM bacteria-based feed additives are designed to improve the texture of livestock feed and inhibit the growth of pathogenic bacteria. Moreover, they deliver essential nutrients such as organic acids, vitamins, enzymes, natural antibiotics, mycelial protein, and various other growth-promoting substances to ensure a balanced nutritional profile in the feed. The FGW bacterial preservatives serve a dual purpose: preserving animal specimens for scientific research and extending the shelf life of agricultural produce. Furthermore, the company supplies bacteria-based fertilizers intended for application directly onto plant foliage, particularly for vegetables and fruits. Beyond its biotechnology endeavors, China Dasheng Biotechnology Company also holds investments in the residential and commercial real estate sectors. The enterprise was previously known as Max Nutrition, Inc., before officially adopting its current name, China Dasheng Biotechnology Company, in March 2008. Its operational headquarters are situated in Lanzhou, China.

China Dasheng Biotechnology Company is headquartered in CN.

China Dasheng Biotechnology Company (CDBT) stock trades at $0.10 with a market capitalization of $4.10M. The stock is valued at a price-to-earnings (P/E) ratio of -4.24, price-to-book of -3.38, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.15, and currently trades 33.3% below its 52-week high.

On profitability, China Dasheng Biotechnology Company generates a return on equity (ROE) of 155.49% — well above the market average, a sign of a high-quality business, return on capital employed of 54.13%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.chinadashengbio.com